SubB Mutant for Detection of Cancer
A mutated form of a novel bacterial toxin binding subunit (SubB) which demonstrates unprecedented binding specificity for cancer biomarkers.
Published: 20th May 2019

Patents
- Australian Patent No. 2004201978
- US Patent No. 7,078,489
- Canadian Patent No. 2,465,009
- PCT/AU2017/051230
Seeking
- Commercial partner